Functional status in a geriatric oncology setting: A review.

[1]  H. Cohen,et al.  Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey. , 2018, European journal of cancer.

[2]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.

[3]  H. Cohen,et al.  Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  C. Chouaid,et al.  Prognostic role of a comprehensive geriatric assessment on the management of elderly patients with advanced non-small cell lung cancer (NSCLC): a pooled analysis of two prospective phase II trials by the GFPC Group. , 2017, Journal of thoracic disease.

[5]  H. Wildiers,et al.  Relevance of Geriatric Assessment in Older Patients With Colorectal Cancer , 2017, Clinical colorectal cancer.

[6]  H. Wildiers,et al.  Value of geriatric screening and assessment in predicting postoperative complications in patients older than 70 years undergoing surgery for colorectal cancer. , 2017, Journal of geriatric oncology.

[7]  E. Blot,et al.  Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  K. Nackaerts,et al.  Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer , 2017, Lung.

[9]  H. Wildiers,et al.  Functional decline in older patients with cancer receiving chemotherapy: A multicenter prospective study. , 2017, Journal of geriatric oncology.

[10]  H. Cohen,et al.  Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance) , 2017, Breast Cancer Research and Treatment.

[11]  A. Secord,et al.  Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study. , 2017, Gynecologic oncology.

[12]  I. Sobhani,et al.  Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients. , 2017, European journal of cancer.

[13]  C. Suemoto,et al.  Functional Status is a Predictor of Postoperative Complications After Cancer Surgery in the Very Old , 2017, Annals of Surgical Oncology.

[14]  F. Chauvin,et al.  Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: Results of a pooled analysis of three GINECO phase II trials. , 2016, Gynecologic oncology.

[15]  Soyeon Ahn,et al.  Use of a Comprehensive Geriatric Assessment to Predict Short-Term Postoperative Outcome in Elderly Patients With Colorectal Cancer , 2016, Annals of coloproctology.

[16]  J. Daurès,et al.  Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  S. Jonna,et al.  Geriatric assessment factors are associated with mortality after hospitalization in older adults with cancer , 2016, Supportive Care in Cancer.

[18]  F. Retornaz,et al.  Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study , 2016, PloS one.

[19]  C. Tournigand,et al.  Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With Cancer. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[20]  A. Vigano,et al.  Screening for predictors of adverse outcome in onco-geriatric surgical patients: A multicenter prospective cohort study. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  V. Vukovic,et al.  Prognostic effect of comorbidity indices in elderly patients with multiple myeloma. , 2015, Clinical lymphoma, myeloma & leukemia.

[22]  A. Iasonos,et al.  Geriatric Assessment as a Predictor of Delirium and Other Outcomes in Elderly Patients With Cancer. , 2015, Annals of surgery.

[23]  S. Barni,et al.  Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  C. Gross,et al.  Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors. , 2015, Journal of geriatric oncology.

[25]  E. Skovlund,et al.  Frailty is an independent predictor of survival in older patients with colorectal cancer. , 2014, The oncologist.

[26]  S. Culine,et al.  Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment , 2014, Clinical interventions in aging.

[27]  H. Wildiers,et al.  International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  L. Thuler,et al.  Predictors of Postoperative Complications, Prolonged Length of Hospital Stay, and Short-Term Mortality in Elderly Patients with Malignant Head and Neck Neoplasm , 2014, ORL.

[29]  C. Tournigand,et al.  Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study. , 2014, The oncologist.

[30]  O. Bouché,et al.  Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  C. Gross,et al.  Toxicity of bevacizumab in combination with chemotherapy in older patients. , 2013, The oncologist.

[32]  M. Lübbert,et al.  Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome , 2013, Haematologica.

[33]  Keun-Wook Lee,et al.  Toxicities and functional consequences of systemic chemotherapy in elderly Korean patients with cancer: A prospective cohort study using Comprehensive Geriatric Assessment , 2012 .

[34]  S. Alibhai,et al.  Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic Review , 2012, Journal of the National Cancer Institute.

[35]  G. Lyman,et al.  Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score , 2012, Cancer.

[36]  R. Talamini,et al.  Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma. , 2012, The oncologist.

[37]  A. Ravaud,et al.  Predictors of early death risk in older patients treated with first-line chemotherapy for cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  J. Gomez-Codina,et al.  Comprehensive Geriatric Assessment (CGA) of elderly lung cancer patients: A single-center experience , 2012 .

[39]  Scott E. Smith,et al.  Analysis of very elderly (≥80 years) non‐hodgkin lymphoma: impact of functional status and co‐morbidities on outcome , 2012, British journal of haematology.

[40]  B. Buurman,et al.  The value of a comprehensive geriatric assessment for patient care in acutely hospitalized older patients with cancer. , 2011, The oncologist.

[41]  S. Culine,et al.  Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  B. Milleron,et al.  Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial , 2011, The Lancet.

[43]  Supriya G Mohile,et al.  Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44]  N. Magné,et al.  Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. , 2011, Critical reviews in oncology/hematology.

[45]  F. Jardin,et al.  Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. , 2011, The Lancet. Oncology.

[46]  C. Wolfson,et al.  Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study. , 2011, Critical reviews in oncology/hematology.

[47]  M. Makuuchi,et al.  The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience , 2009, Annals of surgery.

[48]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[49]  Michael E. Miller,et al.  Measuring disability in older adults: The International Classification System of Functioning, Disability and Health (ICF) framework , 2008, Geriatrics & gerontology international.

[50]  Douglas G Altman,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. , 2014, International journal of surgery.

[51]  Douglas G Altman,et al.  [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]. , 2007, Gaceta sanitaria.

[52]  Kenneth Rockwood,et al.  Long‐Term Risks of Death and Institutionalization of Elderly People in Relation to Deficit Accumulation at Age 70 , 2006, Journal of the American Geriatrics Society.

[53]  H. Cohen,et al.  Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). , 2005, Critical reviews in oncology/hematology.

[54]  K. Slim,et al.  Methodological index for non‐randomized studies (MINORS): development and validation of a new instrument , 2003, ANZ journal of surgery.

[55]  H. Cohen,et al.  Functional status and the elderly cancer patient. , 2002, Critical reviews in oncology/hematology.

[56]  W. Gianni,et al.  Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[58]  P. Novotny,et al.  Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  P. Barberger‐Gateau,et al.  Four Instrumental Activities of Daily Living Score as a predictor of one-year incident dementia. , 1993, Age and ageing.

[60]  G P Samsa,et al.  Comparing Proxy and Patients' Perceptions of Patients' Functional Status: Results from an Outpatient Geriatric Clinic , 1992, Journal of the American Geriatrics Society.

[61]  M A Hlatky,et al.  A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). , 1989, The American journal of cardiology.

[62]  D. Solomon,et al.  Geriatric assessment: methods for clinical decision making. , 1988, JAMA.

[63]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[64]  G. Fillenbaum,et al.  The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. , 1981, Journal of gerontology.

[65]  S. Z. Nagi.  An epidemiology of disability among adults in the United States. , 1976, The Milbank Memorial Fund quarterly. Health and society.

[66]  M. Lawton,et al.  Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .

[67]  I. Rosow,et al.  A Guttman health scale for the aged. , 1966, Journal of gerontology.

[68]  K. Wernecke,et al.  Functional impairment prior to major non-cardiac surgery is associated with mortality within one year in elderly patients with gastrointestinal, gynaecological and urogenital cancer: A prospective observational cohort study. , 2018, Journal of geriatric oncology.

[69]  V. Georgoulias,et al.  Docetaxel plus gemcitabine versus gemcitabine in elderly patients with advanced non-small cell lung cancer and use of a geriatric assessment: Lessons from a prematurely closed Hellenic Oncology Research Group randomized phase III study. , 2017, Journal of geriatric oncology.

[70]  F. Kiyomi,et al.  Retrospective Analysis of Treatment Outcomes and Geriatric Assessment in Elderly Malignant Lymphoma Patients. , 2016, Journal of clinical and experimental hematopathology : JCEH.

[71]  J. W. Kim,et al.  The early discontinuation of palliative chemotherapy in older patients with cancer , 2013, Supportive Care in Cancer.

[72]  N B Lincoln,et al.  The Extended Activities of Daily Living scale: a further validation. , 1992, Disability and rehabilitation.

[73]  D. Karnofsky.  The clinical evaluation of chemotherapeutic agents in cancer , 1949 .